Renfort par vis pour défauts acétabulaires majeurs dans les infections périprothétiques après arthroplastie totale de la hanche - 27/09/22
Screw augmented cement spacer for deficient acetabulum in periprosthetic infection following total hip arthroplasty
, Dong-Wan Kim, Ki-Cheor Bae, Chul-Hyun Cho, Eun-Suck SonAbstract |
For periprosthetic joint infection (PJI) treatment, revision total hip arthroplasty using an antibiotic loaded cement spacer is one of the important surgical methods. However, revision total hip arthroplasty using antibiotic-loaded cement spacers poses a risk of spacer dislodgement in patients with acetabular deficiency. We hypothesized that screw augmentation would be more stable and result in lower rates of cement spacer dislodgement in acetabular deficient patients. Thus, we suggest a method of screw augmentation with cement spacers to treat periprosthetic infection in patients with a deficient acetabulum. And we aim to report better clinical outcomes after revision total hip arthroplasty for infection control using screw augmented cement spacer insertion technique.
Level of evidence |
IV.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Revision, Total hip arthroplasty, Infection, Cement spacer, Acetabular deficiency
Abbreviations : AP, HHS, PJI, THA
| ☆ | Cet article peut être consulté in extenso dans la version anglaise de la revue Orthopaedics & Traumatology: Surgery & Research sur Science Direct (sciencedirect.com) en utilisant le DOI ci-dessus. |
Vol 108 - N° 6
P. 767 - Ottobre 2022 Ritorno al numero
Articolo precedente
- Espaceurs articulés bipolaires vs non-articulés conventionnels : résultats d’une étude comparative dans le traitement en deux temps des ostéoarthrites septiques chroniques sur hanche prothétique ou native
- François Egrise, Mathias Kirsch, Thomas Remen, Olivier Roche, Sybille Bevilacqua, Didier Mainard
- Solutions chirurgicales pour la préparation cutanée avant arthroplastie totale de la hanche : étude coût-efficacité comparative entre l’utilisation de la Betadine® et du Chloraprep ™
- Grégoire Rougereau, Léonard Chatelain, Richard Terracher, Frédéric Zadegan, Didier Ollat
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?